Implementation of national guidelines on antenatal magnesium sulfate for neonatal neuroprotection: extended evaluation of the effectiveness and cost-effectiveness of the National PReCePT Programme in England
The PReCePT QI programme cost-effectively improved use of antenatal MgSO<sub>4</sub>, with anticipated benefits to the babies who have been protected from CP.
Authors
- Carlos Sillero‐Rejon (ORCID: https://orcid.org/0000-0001-5502-9247)
- Karen Luyt (ORCID: https://orcid.org/0000-0002-9806-1092)
- Hannah B Edwards (ORCID: https://orcid.org/0000-0002-1885-4771)
- David Odd (ORCID: https://orcid.org/0000-0002-6416-4966)
- Brent C. Opmeer (ORCID: https://orcid.org/0000-0002-3877-4090)
- Frank de Vocht (ORCID: https://orcid.org/0000-0003-3631-627X)
- Hugh McLeod (ORCID: https://orcid.org/0000-0002-2266-7303)
- Elizabeth Hill
- Colin Peters
Institutions
- Cardiff and Vale University Health Board (GB)
- Royal Hospital for Children (GB)
- University Hospitals Bristol NHS Foundation Trust (GB)
- University of Bristol (GB)
- National Health Care Institute (NL)
- NIHR Applied Research Collaboration West (GB)
- Cardiff University (GB)
Publication Details
- Journal
- BMJ Quality & Safety
- Published
- 2025-04-27
- DOI
- https://doi.org/10.1136/bmjqs-2024-017763
- Citations
- 3
- Primary Topic
- Infant Development and Preterm Care
- Type
- article
- Field-Weighted Citation Impact
- 10.48
Funders
- Health Foundation
- National Institute for Health Research Applied Research Collaboration West